Epithelial–mesenchymal transition (EMT) is a reversible cellular programme in which epithelial cells lose polarity and cell–cell adhesion, acquiring mesenchymal traits including motility and ...

Epithelial-mesenchymal transition (EMT) describes a process by which liver epithelial cells––including hepatocytes and cholangiocytes––lose apical–basal polarity and intercellular adhesion, adopt a ...

Novel prognostic staging system for patients with de novo metastatic breast cancer: A real-world experience. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does ...

Diagram illustrating the epithelial–mesenchymal transition (EMT)-associated signaling pathways involved in the proliferation, invasion, and stemness of glioblastoma (GBM) cells. Major signaling ...

A review of evidence has indicated that the P2Y2 receptor – a purinergic signalling receptor activated by extracellular ...

Metabolic profile and therapeutic vulnerabilities of multi-omic characterization ofKRAS/STK11/KEAP1 co-mutant non–small cell lung cancer (NSCLC). This is an ASCO Meeting Abstract from the 2024 ASCO ...

Lung cancer remains one of the deadliest malignancies worldwide, with distant metastasis representing the major obstacle to effective treatment and ...

Endothelial-mesenchymal transition (EndoMT, also termed as EndMT), a biological process resulting in the formation of mesenchymal (or lineage-committed) phenotypes from endothelial cells (lining blood ...